Chair: Thomas Scammell, MD
Faculty: Richard Bogan, MD; Suresh Kotagal, MD; Emmanuel Mignot, MD
Program Overview:
In this educational initiative, experts in narcolepsy will address
the fundamental components of narcolepsy management:
clinical features, pathophysiology of the disorder, diagnosis, and treatment. In addition, a “hot topics” panel discussion of emerging guidelines (classifications of narcolepsy and potential implications) and challenges in diagnosis and management of narcolepsy in the pediatric population will be included. Significant time will
be allocated for addressing questions from attendees. A case study will be incorporated into the program, utilizing an interactive audience
response system (ARS). This system will provide faculty members with information on potential deficiencies in attendees’ knowledge and clinical practice, and enable
faculty members to explain appropriate patient management.
Educational Objectives:
Upon completion of this program, attendees should be able to:
Explain the pathophysiology of narcolepsy based on
current evidence.
Recognize key elements for making an accurate
diagnosis of narcolepsy.
Identify changes to classification of narcolepsy from
emerging guidelines.
Summarize nonpharmacologic and symptom-directed pharmacologic treatment in adults and evaluate
efficacy and safety profiles of therapies.
Describe the challenges of diagnosis and management of narcolepsy in the pediatric population.
Target Audience:
This educational activity is intended for healthcare professionals
involved in the management of sleep disorders.
Accreditation Statement:
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statements:
Voxmedia LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Voxmedia International gratefully acknowledges the educational grant provided by Jazz Pharmaceuticals, Inc.
